Search Results - "Mousseau, M."

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1) by Bonnefoi, H., Grellety, T., Tredan, O., Saghatchian, M., Dalenc, F., Mailliez, A., L'Haridon, T., Cottu, P., Abadie-Lacourtoisie, S., You, B., Mousseau, M., Dauba, J., Del Piano, F., Desmoulins, I., Coussy, F., Madranges, N., Grenier, J., Bidard, F.C., Proudhon, C., MacGrogan, G., Orsini, C., Pulido, M., Gonçalves, A.

“…Several expression array studies identified molecular apocrine breast cancer (BC) as a subtype that expresses androgen receptor (AR) but not estrogen receptor…”
Get full text

cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator by Tinckam, K. J., Liwski, R., Pochinco, D., Mousseau, M., Grattan, A., Nickerson, P., Campbell, P.

“…A calculated panel reactive antibody (cPRA) estimates the percentage of donors with unacceptable antigens (UA) for a recipient. cPRA may be underestimated in…”
Get full text

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601 by Ferrand, F, Malka, D, Bourredjem, A, Allonier, C, Bouché, O, Louafi, S, Boige, V, Mousseau, M, Raoul, J.L, Bedenne, L, Leduc, B, Deguiral, P, Faron, M, Pignon, J.P, Ducreux, M

“…Abstract Objective To assess the impact of primary tumour resection on overall survival (OS) of patients diagnosed with stage IV colorectal cancer (CRC)…”
Get full text

Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer by Pluchart, H., Jacquet, E., Charlety, D., Allenet, B., Bedouch, P., Mousseau, M.

“…We report the case of a woman with metastatic breast cancer receiving intrathecal trastuzumab (and intravenous trastuzumab for more than 7 years). She was…”
Get full text

A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil–epirubicine–cyclophosphamide (FEC100 ) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000) by Delbaldo, C, Serin, D, Mousseau, M, Greget, S, Audhuy, B, Priou, F, Berdah, J.F, Teissier, E, Laplaige, P, Zelek, L, Quinaux, E, Buyse, M, Piedbois, P

“…Abstract Background Standard adjuvant chemotherapy regimens for patients with node positive (N+) breast cancer consisted of anthracycline followed by taxane…”
Get full text

A model for the measurement of patient activity in a hospital suite by LeBellego, G., Noury, N., Virone, G., Mousseau, M., Demongeot, J.

“…At the time of hospitalization, it is essential to evaluate the general health status of a patient and to follow up the trends during therapy. Our work is…”
Get full text

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy by Rougier, P, Bugat, R, Douillard, J Y, Culine, S, Suc, E, Brunet, P, Becouarn, Y, Ychou, M, Marty, M, Extra, J M, Bonneterre, J, Adenis, A, Seitz, J F, Ganem, G, Namer, M, Conroy, T, Negrier, S, Merrouche, Y, Burki, F, Mousseau, M, Herait, P, Mahjoubi, M

“…To assess the efficacy of irinotecan (CPT-11) in the treatment of advanced colorectal cancer in both chemotherapy-naive and pretreated patients. Two hundred…”
Get more information

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study by Roy, A, Cunningham, D, Hawkins, R, Sörbye, H, Adenis, A, Barcelo, J-R, Lopez-Vivanco, G, Adler, G, Canon, J-L, Lofts, F, Castanon, C, Fonseca, E, Rixe, O, Aparicio, J, Cassinello, J, Nicolson, M, Mousseau, M, Schalhorn, A, D'Hondt, L, Kerger, J, Hossfeld, D K, Garcia Giron, C, Rodriguez, R, Schoffski, P, Misset, J-L

“…Background: Docetaxel and irinotecan chemotherapy have shown good efficacy in the treatment of advanced oesophago-gastric cancer. This randomised phase II…”
Get full text

Pathways to purpose among impoverished youth from the Guatemala City Dump community by Liang, Belle, White, Allison, Rhodes, Haley, Strodel, Rachel, Gutowski, Ellen, DeSilva Mousseau, Angela M, Lund, Terese Jean

“…Nongovernmental organizations (NGOs), such as Potter’s House Association (PHA), work to build capacity in impoverished communities surrounding the Guatemala…”
Get full text

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma by Mornex, F, Thomas, L, Mohr, P, Hauschild, A, Delaunay, M M, Lesimple, T, Tilgen, W, Bui, B N, Guillot, B, Ulrich, J, Bourdin, S, Mousseau, M, Cupissol, D, Bonneterre, M E, De Gislain, C, Bensadoun, R J, Clavel, M

“…The main objective of this prospective multicentre randomized phase III study was to compare a combined regimen of fotemustine plus whole brain irradiation…”
Get full text

Having It All? A Qualitative Examination of Affluent Adolescent Girls’ Perceptions of Stress and Their Quests for Success by Spencer, Renée, Walsh, Jill, Liang, Belle, Mousseau, Angela M. Desilva, Lund, Terese J.

“…This study sought to better understand the relationship between affluence and elevated risk for psychosocial distress among adolescent girls. In-depth…”
Get full text

Effects of permeability transition inhibition and decrease in cytochrome c content on doxorubicin toxicity in K562 cells by DE OLIVEIRA, F, CHAUVIN, C, RONOT, X, MOUSSEAU, M, LEVERVE, X, FONTAINE, E

“…As mitochondria play a key role in the commitment to cell death, we have investigated the mitochondrial consequences of resistance to doxorubicin (DOX) in K562…”
Get full text

Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy by Pujade-Lauraine, E, Guastalla, J P, Colombo, N, Devillier, P, François, E, Fumoleau, P, Monnier, A, Nooy, M, Mignot, L, Bugat, R, Marques, C, Mousseau, M, Netter, G, Maloisel, F, Larbaoui, S, Brandely, M

“…The purpose of this study was to evaluate the efficacy and tolerance of recombinant human interferon gamma (rIFN-gamma) as second-line treatment in patients…”
Get more information

The Direct Effect of Increased CO2 on Gas Exchange and Growth of Forest Tree Species by MOUSSEAU, M., SAUGIER, B.

“…CO2 enrichment of the atmosphere is now well documented and its effect on the growth of world forests is being questioned by the scientific community. The…”
Get full text

Analysis of the Mw 4.3 Lorient earthquake sequence: a multidisciplinary approach to the geodynamics of the Armorican Massif, westernmost France by Perrot, J., Arroucau, P., Guilbert, J., Déverchère, J., Mazabraud, Y., Rolet, J., Mocquet, A., Mousseau, M., Matias, L.

“…A Mw 4.3 earthquake occurred on 2002 September 30, in the Armorican Massif, NW France. Since it was one of the largest events ever recorded in this region,…”
Get full text

THE MEDIATING ROLE OF ENGAGEMENT IN MENTORING RELATIONSHIPS AND SELF-ESTEEM AMONG AFFLUENT ADOLESCENT GIRLS by Liang, Belle, Lund, Terese Jean, Mousseau, Angela M. Desilva, Spencer, Renée

“…This study examined the influence of growth‐fostering mentoring relationships on the self‐esteem of adolescent female students from affluent communities…”
Get full text

Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial by Ducreux, M, Bouche, O, Pignon, J P, Mousseau, M, Raoul, J L, Cassan, P, Leduc, B, Berger, C, Dunant, A, Fournet, J, Bedenne, L

“…LV5FU2 with high-dose leucovorin (LV), weekly infusional 5-fluorouracil (5FU) (AIO schedule) and raltitrexed have been demonstrated to be active agents in…”
Get more information

Randomized Multicenter Phase II Study Comparing a Combination of Fluorouracil and Folinic Acid and Alternating Irinotecan and Oxaliplatin With Oxaliplatin and Irinotecan in Fluorouracil-Pretreated Metastatic Colorectal Cancer Patients by BECOUARN, Yves, GAMELIN, Erick, BEKRADDA, Mohamed, MIGNARD, Dominique, MOUSSEAU, Mireille, COUDERT, Bruno, NEGRIER, Sylvie, PIERGA, Jean-Yves, RAOUL, Jean-Luc, PROVENCAL, Jocelyne, RIXE, Olivier, KRISCH, Claude, GERMA, Caroline

“…To assess antitumor activity and safety of two regimens in advanced colorectal cancer (CRC) patients with proven fluorouracil (5-FU) resistance in a randomized…”
Get full text

Contribution of dynamic interpretation of CA 125 measurements to the understanding of an atypical clinical case by Riedinger, J-M, Mousseau, M, Gauchez, A-S

“…The dynamic interpretation of the serum concentrations of markers is frequently used to calculate biological indicators of therapeutic efficiency and relapse…”
Get more information

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer : toxicity and response (PEGASE 02 trial) by VIENS, P, PALANGIE, T, COSTA, B, DELVA, R, CURE, H, ROUSSEAU, F, GUILOT, A, MOUSSEAU, M, FERRERO, J. M, BARDOU, V. J, JACQUEMIER, J, POUILLART, P, JANVIER, M, FABBRO, M, ROCHE, H, DELOZIER, T, LABAT, J. P, LINASSIER, C, AUDHUY, B, FEUILHADE, F

“…Despite the generalization of induction chemotherapy and a better outcome for chemosensitive diseases, the prognosis of inflammatory breast cancer (IBC) is…”
Get full text